HopeStage
Back to all studies
SuspendedNCT05719909

Testing the Effectiveness of Cognitive Training Among Depressed Patients Receiving Esketamine Treatment

Researchers are comparing training for memory, attention and thinking skills and a simulated comparison procedure to find out how the approaches affect depression symptoms in people with depression.

Behavioural studyAges 18–80United States
The study in practice

Understand this study

What is this study about?

Researchers are comparing training for memory, attention and thinking skills and a simulated comparison procedure to find out how the approaches affect depression symptoms in people with depression.

Who could participate?

Listed age limits: 18 years to 80 years.

Listed locations
PittsburghSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: February 14, 2023
Recruitment status
Suspended
Enrollment listed in the registry
40
Sponsor
University of Pittsburgh
Sponsor type
University
Study type
Behavioral
Intervention type
Behavioural
Locations
United States
Age range
From 18 Years to 80 Years
Official registry ID
NCT05719909
Official title
Show the full official title

Cognitive Training to Enhance Depression Relief: Testing an Adjunct to Clinical Esketamine Treatment

Recruitment & locations

Suspended

Pittsburgh

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

What is this study about?

Researchers are comparing training for memory, attention and thinking skills and a simulated comparison procedure to find out how the approaches affect depression symptoms in people with depression.

Who is behind this study?

The study sponsor is University of Pittsburgh, a university.

Who can participate?

Listed age limits: 18 years to 80 years.

Is this study still recruiting?

The registry lists this study as suspended.

Want to explore more studies?

Explore studies